TA Associates buys 16% of Indian pathology company

The US-headquartered firm bought a portion of its stake in Delhi-based Dr Lal Pathlabs from previous investor Sequoia Capital.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this